Pages that link to "Q24531982"
Jump to navigation
Jump to search
The following pages link to Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells (Q24531982):
Displaying 50 items.
- Emerging roles of PDGF-D in EMT progression during tumorigenesis (Q26859634) (← links)
- Mice Lacking Platelet-Derived Growth Factor D Display a Mild Vascular Phenotype (Q27316378) (← links)
- Circadian Rhythm Disruption in Cancer Biology (Q28972554) (← links)
- Pharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disorders (Q29048615) (← links)
- Mass spectrometry-based secretome analysis of non-small cell lung cancer cell lines (Q30313775) (← links)
- PDGF-DD, a novel mediator of smooth muscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosis-prone flow patterns (Q30437153) (← links)
- Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells (Q30988612) (← links)
- An integrative approach to characterize disease-specific pathways and their coordination: a case study in cancer (Q33325593) (← links)
- 3'UTR shortening identifies high-risk cancers with targeted dysregulation of the ceRNA network. (Q33788981) (← links)
- Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progression (Q33866927) (← links)
- Emerging roles of PDGF-D signaling pathway in tumor development and progression (Q33912608) (← links)
- Targeting the PDGF signaling pathway in the treatment of non-malignant diseases (Q34352802) (← links)
- Targeting the PDGF signaling pathway in tumor treatment (Q34393461) (← links)
- A novel signaling axis of matriptase/PDGF-D/ß-PDGFR in human prostate cancer (Q34683885) (← links)
- MUC1 protein induces urokinase-type plasminogen activator (uPA) by forming a complex with NF-κB p65 transcription factor and binding to the uPA promoter, leading to enhanced invasiveness of cancer cells (Q34737810) (← links)
- miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells (Q34988143) (← links)
- Interleukin-like epithelial-to-mesenchymal transition inducer activity is controlled by proteolytic processing and plasminogen-urokinase plasminogen activator receptor system-regulated secretion during breast cancer progression (Q34999819) (← links)
- Dynamic regulation of platelet-derived growth factor D (PDGF-D) activity and extracellular spatial distribution by matriptase-mediated proteolysis (Q35580879) (← links)
- Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM (Q35839941) (← links)
- Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: implications for breast cancer progression (Q35929823) (← links)
- PTEN regulates PDGF ligand switch for β-PDGFR signaling in prostate cancer (Q35952035) (← links)
- Cediranib inhibits both the intraosseous growth of PDGF D-positive prostate cancer cells and the associated bone reaction (Q36013452) (← links)
- A novel function for platelet-derived growth factor D: induction of osteoclastic differentiation for intraosseous tumor growth (Q36352562) (← links)
- Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile (Q36477174) (← links)
- PDGF receptors as targets in tumor treatment (Q36786075) (← links)
- Distinct effects of ligand-induced PDGFRα and PDGFRβ signaling in the human rhabdomyosarcoma tumor cell and stroma cell compartments. (Q36903863) (← links)
- Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis (Q36934781) (← links)
- Mammalian target of rapamycin repression by 3,3'-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC3 cells (Q37132900) (← links)
- Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells (Q37154190) (← links)
- Activated K-Ras and INK4a/Arf deficiency promote aggressiveness of pancreatic cancer by induction of EMT consistent with cancer stem cell phenotype (Q37184447) (← links)
- Inactivation of uPA and its receptor uPAR by 3,3'-diindolylmethane (DIM) leads to the inhibition of prostate cancer cell growth and migration (Q37335608) (← links)
- Over-expression of platelet-derived growth factor-D promotes tumor growth and invasion in endometrial cancer (Q37684112) (← links)
- Autocrine PDGF stimulation in malignancies (Q38003387) (← links)
- Platelet-derived growth factors and their receptors: structural and functional perspectives (Q38058615) (← links)
- Therapeutic targeting of platelet-derived growth factor receptors in solid tumors (Q38160946) (← links)
- Platelet-derived growth factor signaling in the lung. From lung development and disease to clinical studies (Q38258904) (← links)
- Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases (Q38296878) (← links)
- The interaction between androgen receptor and PDGF-D in the radiation response of prostate carcinoma. (Q38806364) (← links)
- Down-regulation of platelet-derived growth factor-D expression blockades NF-κB pathway to inhibit cell proliferation and invasion as well as induce apoptosis in esophageal squamous cell carcinoma (Q39237027) (← links)
- PDGF-D/PDGF-ββ receptor-regulated chemotaxis of malignant mesothelioma cells (Q39380409) (← links)
- Inhibitory effect of soluble platelet-derived growth factor receptor β on intraosseous growth of breast cancer cells in nude mice (Q39511922) (← links)
- Curcumin Facilitates Fibrinolysis and Cellular Migration during Wound Healing by Modulating Urokinase Plasminogen Activator Expression (Q39632834) (← links)
- Identification and expression analysis of an N-terminally truncated isoform of human PDGF-C. (Q39966947) (← links)
- The recombinant kringle domain of urokinase plasminogen activator inhibits in vivo malignant glioma growth (Q40181966) (← links)
- The uPA/uPAR system regulates the bioavailability of PDGF-DD: implications for tumour growth (Q42806622) (← links)
- PDGF receptors are activated in human epiretinal membranes (Q43116460) (← links)
- Clinical significance of platelet derived growth factor-C and -D in gastric cancer (Q43147517) (← links)
- Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor. (Q49590083) (← links)
- Mechanisms of cardiac fibrosis induced by urokinase plasminogen activator. (Q53631087) (← links)
- Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways. (Q54433179) (← links)